Skip to main content
. 2015 Dec 1;4(3):146–155. doi: 10.15420/aer.2015.4.3.146

Table 3: In Vivo miRNA Manipulation in the Context of AF.

MiRNA Species/model MiRNA manipulation Route of administration References
Mir-1 Rabbit ± RA tachypacing Overexpression: lentivirus construct containing mir-1 precursor sequence Direct i.m. Injection into RA 31
Knockdown: lentivirus construct containing anti-mir-1 oligonucleotide sequence Direct i.m. Injection into RA
Mir-21 Rat ± myocardial infarction Knockdown: mir-21 antagomiR Direct i.m. Injection into LA 49
Mir-21 Mouse ± myocardial infarction Knockdown: mir-21 antagomiR Intravenous 48
Mir-26 Mouse (wild type) Overexpression: adeno-associated virus containing mir-26a mimic Intravenous 35
Knockdown: adeno-associated virus containing anti-mir-26a sequence Intravenous
Target protection: adeno-associated virus containing KCNJ2 mask Intravenous
Mir-29b Mouse (wild type) Knockdown: adeno-associated virus containing anti-mir-29b sponge Intravenous 54
Mir-328 Dog ± RA tachypacing Overexpression: adeno-associated virus containing mir-328 precursor sequence Direct i.m. Injection into RA 42
Dog ± RA tachypacing Knockdown: coinjection of mir-328 antagomiR Direct i.m. Injection into RA
Mouse (wild type) Knockdown: mir-328 antagomiR Intravenous

i.m. = intramuscular; LA = left atrium; RA = right atrium.